Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Mallinckrodt Receives FDA Acceptance of Stannsoporfin New Drug Application Filing

Saturday, February 24, 2018

Mallinckrodt plc a leading global specialty pharmaceutical company today announced the US Food and Drug Administration FDA has accepted its New Drug Application NDA seeking approval of its recently acquired developmental product stannsoporfin If appr...

MYR Pharma Announces Completion of Active Treatment Phase in MYR 203 Clinical Trial of Myrcludex B

Friday, February 23, 2018

MYR Pharma GmbH today announced the completion of the weeklong active treatment phase in MYR clinical trial a part of Phase b program investigating Myrcludex B in combination with pegylated interferon PEG INF in chronic hepatitis Delta HDV infection...

Kite, a Gilead Company, And Sangamo Therapeutics Announce Collaboration

Friday, February 23, 2018

Kite a Gilead Company and Sangamo Therapeutics Inc today announced the companies have entered into a worldwide collaboration using Sangamos zinc finger nuclease ZFN technology platform for the development of nextgeneration ex vivo cell therapies in o...

ATUM and Just Biotherapeutics Team Up to Accelerate Drug Discovery

Thursday, February 22, 2018

Dedicated to creating technologies and tools to improve peoples lives ATUM today announced a patent licensing agreement giving Just Biotherapeutics access to the companys LeapIn cell line development tools We love everything about Justs mission an...

Merck and Viralytics Announce Acquisition Agreement, Expanding Merck’s Leading Immuno-Oncology Pipeline

Thursday, February 22, 2018

Merck known as MSD outside the United States and Canada and Viralytics Limited announced that the companies have signed a definitive agreement under which it is proposed that Merck through a subsidiary will acquire Viralytics an Australian publicly t...

Arix Bioscience and Ipsen Sign a Strategic Agreement to Develop and Commercialise Innovative Therapies

Wednesday, February 21, 2018

Arix Bioscience plc a global healthcare and life science company supporting medical innovation and Ipsen a global specialtydriven biopharmaceutical company focused on innovation and specialty care today announced a strategic agreement to develop and...

Novartis readies to auction U.S. generic pills business

Tuesday, February 20, 2018

Switzerlands Novartis AG is preparing to auction its US generic pill business looking to shed a unit that has struggled amid fierce price competition people familiar with the matter said on Friday The move illustrates how the unit has diverged fro...

DanDrit Biotech Announces Completion Of The Acquisition Of Enochian

Tuesday, February 20, 2018

DanDrit Biotech USA Inc is pleased to announce the completion of its previously reported acquisition the Acquisition of Enochian Biopharma Inc Enochian on February As a result of the Acquisition DanDrit owns a perpetual fully paid up royalty free s...

AstraZeneca's immunotherapy drug wins key lung cancer approval

Monday, February 19, 2018

AstraZenecas immunotherapy drug Imfinzi has won crucial approval from US regulators for use in lung cancer opening up a multibilliondollar market for a medicine that has so far lagged behind competitors The US Food and Drug Administration FDA said...

Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-AAT

Friday, February 16, 2018

Arrowhead Pharmaceuticals Inc announced the United States Food and Drug Administration FDA has granted orphan drug designation to AROAAT Arrowheads secondgeneration investigational medicine for the treatment of a rare genetic liver disease associated...